Updated:
ChargePoint Technology
ChargePoint Technology is based in Liverpool; the profile covers headquarters, registration, AUM band and key contacts for private-markets fundraising.
Overview
ChargePoint Technology specialises in pharmaceutical containment & aseptic processing with patented powder transfer systems
General information
Location
Region
Europe
Country
United Kingdom
City
Liverpool
Corporate office
Liverpool, United Kingdom
Additional offices
New Jersey, United States · Boston, United States
Frequently asked questions
What is the core product technology at ChargePoint Technology?
ChargePoint Technology's core product is a split butterfly valve for high-containment and aseptic powder transfer, originally developed in 1997 with Glaxo Pharmaceuticals (now GSK). The company also produces single-use powder packaging bags (ChargeBag® PE-S and ChargeBag® XL), fluid management systems (Terracon™ and TerraPure®), and robotic powder-handling equipment.
What industries does ChargePoint Technology serve?
ChargePoint Technology serves the pharmaceutical, biopharmaceutical, and life science industries. Its equipment is used for handling potent active pharmaceutical ingredients (APIs), aseptic processing, and sterile powder transfer in drug manufacturing.
Where is ChargePoint Technology headquartered and what are its other locations?
ChargePoint Technology is headquartered at Venture Point Business Park, Liverpool, United Kingdom. It also has sales and service offices in New Jersey, United States, and a manufacturing, sales, and service facility in Boston, Massachusetts, operating as Terracon Corp.
Does ChargePoint Technology offer after-sales support?
Yes, ChargePoint Technology operates an AfterCare team that provides installation support, spare parts, tailored maintenance packages, training, and local engineering support for its powder transfer systems.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: